Chlamydia pneumoniae in HIV-infected patients and controls assessed by a novel whole blood interferon-γ assay, serology and PCR I.J. Woolley, M. Larsen,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

P.-Y. Lévy Clinical Microbiology and Infection

R. Dumke, H. von Baum, P.C. Lück, E. Jacobs

Chlamydia pneumoniae in HIV-infected patients and controls assessed by a novel whole blood interferon-γ assay, serology and PCR I.J. Woolley, M. Larsen,

L. Boyanova Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

Approach to diagnosis of infective endocarditis

R. Colodner, O. Nitzan, B. Chazan, H. Edelstein, R. Raz

Migrant health—a cause for concern?

J. M. Pereira, R. P. Moreno, R. Matos, A. Rhodes, I. Martin-Loeches, M

E. Bronska, J. Kalmusova, O. Dzupova, V. Maresova, P. Kriz, J. Benes

J. M. Pereira, R. P. Moreno, R. Matos, A. Rhodes, I. Martin-Loeches, M

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

R. Cantón Clinical Microbiology and Infection

Genital Chlamydia trachomatis infections

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Link between intracellular pathogens and cardiovascular diseases

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Surveillance of Legionnaires’ disease in Austria

Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain J.-M. Aguado, C. Lumbreras, D.

Vector control: a cornerstone in the malaria elimination campaign

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Training for the infectious diseases speciality in Norway

Elements of design: the knowledge on which we build

Levofloxacin in the treatment of ventilator-associated pneumonia

Metagenomics and probiotics

Laboratory diagnosis of Clostridium difficile disease

The practice of travel medicine in Europe

T.M. File Clinical Microbiology and Infection

Update on antifungal resistance in Aspergillus and Candida

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures A. Makristathis, S. Riss, A.M. Hirschl

Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection R. Nir-Paz, A. Michael-Gayego, M. Ron, C.

Current experience in treating invasive zygomycosis with posaconazole

D. Hvidsten, D.S. Halvorsen, B.P. Berdal, T.J. Gutteberg

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.

An after-hours clinical liaison blood culture service—is it worth it?

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis Miles Denton, Kevin G Kerr, Fraser Lewis Clinical.

Overview of cefixime use in community-acquired infections

Tuberculosis in HIV-infected patients: a comprehensive review

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Multiplexed whole bacterial antigen microarray, a new format for the automation of serodiagnosis: the culture-negative endocarditis paradigm F. Gouriet,

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Abstracts Clinical Microbiology and Infection

Serum ferritin levels in West Nile encephalitis

Modelling during an emergency: the 2009 H1N1 influenza pandemic

D. Baud, C. Kebbi, J.-P. Külling, G. Greub

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Clinical microbiological case: thermointolerant microorganism growth in blood cultures and catheter tip M. Blasco-Navalpotro, M. Jordán, J.J. Camarena,

Three years experience of real-time PCR for the diagnosis of Q fever

Typing of Clostridium difficile

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

Rajko Saletinger, Mario Poljak, Franc Strle

The future of diagnostic bacteriology

Presentation transcript:

Chlamydia pneumoniae in HIV-infected patients and controls assessed by a novel whole blood interferon-γ assay, serology and PCR I.J. Woolley, M. Larsen, S. Jones, M.E. Gahan, I. Jasenko, S.P. Johnsen, S. Wesselingh, A. Fuller, L. Ostergaard Clinical Microbiology and Infection Volume 10, Issue 9, Pages 820-825 (September 2004) DOI: 10.1111/j.1198-743X.2004.00952.x Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Relationship between interferon-γ response and serum IgG and IgA response to Chlamydia pneumoniae in normal controls and HIV-infected patients. Clinical Microbiology and Infection 2004 10, 820-825DOI: (10.1111/j.1198-743X.2004.00952.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions